MiMedx Group Inc (MDXG)

8.52
0.17 2.00
NASDAQ : Health Care
Prev Close 8.35
Open 8.42
Day Low/High 8.21 / 8.52
52 Wk Low/High 6.64 / 12.83
Volume 130.90K
Avg Volume 840.00K
Exchange NASDAQ
Shares Outstanding 110.04M
Market Cap 952.97M
EPS 0.30
P/E Ratio 45.35
Div & Yield N.A. (N.A)

Latest News

Scientific Study Confirms How MiMedx DHACM Allografts Effectively Promote Wound Repair

Scientific Study Confirms How MiMedx DHACM Allografts Effectively Promote Wound Repair

Study quantifies in MiMedx dHACM allografts numerous matrix components, growth factors, proteases and protease inhibitors known to play a role in wound healing

MiMedx Announces Nationwide Launch of AmnioFill™

MiMedx Announces Nationwide Launch of AmnioFill™

AMNIOFILL™ IS THE FIRST PRODUCT IN THE MIMEDX PLACENTAL COLLAGEN MATRIX FAMILY TO BE COMMERCIALLY INTRODUCED

MiMedx Provides Update On Key Clinical Trials

MiMedx Provides Update On Key Clinical Trials

FDA AGREES TO SHORTEN IMMUNOGENIC TESTING BY ONE YEAR IN THE COMPANY'S PLANTAR FASCIITIS STUDY

MiMedx Group (MDXG) Weak On High Volume

MiMedx Group (MDXG) Weak On High Volume

Trade-Ideas LLC identified MiMedx Group (MDXG) as a weak on high relative volume candidate

MiMedx Announces Nationwide Launch Of New Ambient Temperature Version Of OrthoFlo

MiMedx Announces Nationwide Launch Of New Ambient Temperature Version Of OrthoFlo

New Lyophilized OrthoFlo version is an advancement in product logistics and safety

MiMedx Second Quarter Of 2016 Revenue Exceeds Upper End Of Guidance Range

MiMedx Second Quarter Of 2016 Revenue Exceeds Upper End Of Guidance Range

$57.3 MILLION Q2 2016 REVENUE IS 26% INCREASE OVER Q2 2015

MiMedx Group Breaks Above 200-Day Moving Average - Bullish for MDXG

MiMedx Group Breaks Above 200-Day Moving Average - Bullish for MDXG

In trading on Friday, shares of MiMedx Group Inc crossed above their 200 day moving average of $8.34, changing hands as high as $8.38 per share. MiMedx Group Inc shares are currently trading up about 2.7% on the day.

MiMedx Adds New Executive

MiMedx Adds New Executive

Independent Clinical Case Series Demonstrates MiMedx DHACM, Along With Split Thickness Skin Grafts, Is Effective In Limb Salvage

Independent Clinical Case Series Demonstrates MiMedx DHACM, Along With Split Thickness Skin Grafts, Is Effective In Limb Salvage

Case series determines wounds with exposed bone or tendon treated with dHACM and STSG is viable low-cost treatment alternative to the gold standard for limb salvage

MiMedx Goes After Osiris With Lawsuit

MiMedx Goes After Osiris With Lawsuit

The wound care provider filed the suit for allegedly falsifying and misleading consumers with clinical data.

MiMedx Provides Reminder Of May 18th Annual Shareholders Meeting

MiMedx Provides Reminder Of May 18th Annual Shareholders Meeting

Company Reiterates Second Quarter Guidance

Trade-Ideas: MiMedx Group (MDXG) Is Today's Strong On High Relative Volume Stock

Trade-Ideas: MiMedx Group (MDXG) Is Today's Strong On High Relative Volume Stock

Trade-Ideas LLC identified MiMedx Group (MDXG) as a strong on high relative volume candidate

MDXG: Insiders vs. Shorts

MDXG: Insiders vs. Shorts

The most recent short interest data was recently released for the 03/31/2016 settlement date, and MiMedx Group Inc is one of the most shorted stocks of the Russell 3000, based on 19.83 "days to cover" versus the median component at 6.16. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

MiMedx Group Becomes Oversold (MDXG)

MiMedx Group Becomes Oversold (MDXG)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

MiMedx Comments On Flawed Osiris Data Review

MiMedx Comments On Flawed Osiris Data Review

Review is flawed with unmatched, uncontrolled and subjective variables

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABEV, ALSN, BANR, CPHR, FARM, FBP, FOX, FOXA, HDS, HL, KMDA, MSM, PBA, QUOT, SAMG, SCHN, XNCR Downgrades: AGNC, EJ, MDXG, XRX, ZHNE Initiations: COYN Read on to get TheStreet Quant Ratings' detailed report:

Utilities Finally Break

This move is important, because utilities are a leading indicator.